February 12th, 2015
Discontinuing Aspirin for Primary Prevention: What Do You Say to Your Patient?
Harlan M. Krumholz, MD, SM
In this scenario based on a study that found once-daily, low-dose aspirin did not significantly reduce the risk for CV events among older patients with atherosclerotic risk factors, Harlan Krumholz asks, “What do you say to your patient?”
December 1st, 2014
Selections from Richard Lehman’s Literature Review: December 1st
Richard Lehman, BM, BCh, MRCGP
This week’s topics include atenolol vs. losartan in children and young adults with Marfan’s syndrome, the Japanese Primary Prevention Project, and more.
NEJM Journal Watch — Recent Cardiology Articles- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?